Elderly hypertensive patients with cardiovascular disease may benefit from combination antihypertensive therapy

Adding a second antihypertensive medication appears to be more beneficial than increasing the dose of a single antihypertensive in reducing all-cause mortality cardiovascular outcomes in patients with cardiovascular disease (CVD). This was the main finding of a recent randomized trial that sought to determine the efficacy of high-dose angiotensin receptor blocker (ARB) therapy vs the addition of a calcium channel blocker (CCB) to a standard dose ARB in patients with CVD or type 2 diabetes.

In India, CVD has been cited to be the leading cause of death in both urban and rural areas, and its incidence is...

Log in or register for free to continue reading
Register Now For Free Already Registered? Log In
This entry was posted in Cardiovascular Disease, Geriatrics, Hypertension, Non-Communicable Disease, Non-Communicable Disease Featured 2, Pharmacology, Primary Care and tagged , , , , , , , , , , , , , , , , , . Volume: .

Post a Comment

You must be logged in to post a comment.